Optical News

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis launches Opuviz (aflibercept) in Europe....

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision, today announced that the company will present at the Eye Bank Association of America (EBAA) 2026 Annual Meeting, taking place in Indianapolis, Indiana, from June 3-6 and at the American-European Congress of Ophthalmic Surgery (AECOS) 2026 European Symposium, June 11-14 in Madrid, Spain. Aurion has been invited for the f...

NEW YORK--(BUSINESS WIRE)--Warby Parker Inc. (NYSE: WRBY) (the “Company”), a lifestyle brand focused on vision for all, today announced that the Company will be presenting at the 2026 Baird Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 at 12:50 pm Eastern Time. The presentation will be webcast live over the internet and can be accessed at https://investors.warbyparker.com/. An online archive will be available for a period of 90 days following the presentation. A...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subscription that brings together free and low-cost generic medications, affordable online care visits, and savings on additional healthcare services in one simple program. Built for a healthcare environment where consumers are increasingly shouldering more out-of-pocket costs, even when they have insurance, Companion tu...

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced management will participate in two upcoming investor conferences: 2026 Jefferies Global Healthcare Conference 1x1 Meetings: Tuesday, June 2 New York, NY Evercore 2026 Emerging Private Biotech Conference Ophthalmology Panel: Wednesday, June 24, 8:50 a.m. ET Newport, RI About Ollin Biosciences Established in 2023, Ollin Bios...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that members of its management team will participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference: Fireside chat on Wednesday, June 3, 2026, at 5:30pm ET in New York, NY Goldman Sachs 47th Annual Global Healthcare...

SMITHFIELD, R.I.--(BUSINESS WIRE)--FGX International, an EssilorLuxottica company and one of the world’s leading over-the-counter eyewear brands, has announced a new partnership with ITV Studios, home of one of the most-watched reality TV series worldwide, Love Island. Inspired by the playful, high-energy world of the blockbuster reality series Love Island and blending villa-ready style with Foster Grant’s signature accessible fashion, Love Island x Foster Grant embodies confidence, connection,...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase announced the successful completion of the first commercial FLIGHT procedures, marking a new era in interventional glaucoma....

WATERTOWN, Mass.--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has received approval from the KRX to proceed with its Initial Public Offering (IPO). The move marks a pivotal transition for the company, supported by a robust pipeline that includes two clinical-stage assets, one of which is IGT-427 (now called MK-8748), an investigational bi-specific antibody (Anti-VEGF/TIE2), for p...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. Webcas...